New CEO to announce outcome of new restructuring plan in Jan Feb, what's he going to say?
"Clearly AZ need a new R&I and CVGI centre. There's one just of the A6 in the Loughborough that's about the perfect size for a streamlined organisation. Now if only that site had a history of delivering R&I and CVGI products... oh wait... it does!"
As someone who worked at Charnwood for many years I'd say that's stretching it a bit. The last thing to come out of Charnwood was Brilinta and that dates back to the 90's and it's hardly been a runaway success - global annual sales of Brilinta for 2012 were a paltry $89million so nothing to shout about. The whole of AZ since the merger has been completely unproductive, no site can escape the blame.
"What?! The sacred cow of Alderley Park is vulnerable - I think not"
Sacred Cow or Fatted Calf?
Clearly AZ need a new R&I and CVGI centre. There's one just of the A6 in the Loughborough that's about the perfect size for a streamlined organisation. Now if only that site had a history of delivering R&I and CVGI products... oh wait... it does!
RIRA and CVGI at Alderley have already been closed. Only oncology is left and Soriot has not mentioned that as one of his priorities for AZ - Alderley is definitely vulnerable.
Fully agree on R&I status, even if there might be a few promising projects left, frequent strategies changes will probably mange to kill them to. Really amazing that they think that changing focus every year can improve the pipeline when it takes 8-10 year to develop a new product. I was formerly in RI and was sacked. I have new job now and is very happy to have left AZ. It will not be a fun trip the coming years.
Although its not all roses at AP
9.00 arrive have coffee
9.30 plan the day
10.00 hr meeting
10.30 meeting with boss to review yesterday
1130 review plan for the day
12.00 stab someone in the back
1.30 make a presentation
2.30 meeting to congratulate team on how successful we are
4.00 review plan for the day - no time for experiment so add to plan for tomorrow
4.30 go home
There is nothing of R&I to move it was destroyed in the last cunning plan. Unfortunately all of AZ has been fixated with restructuring,, hr gobbledygook and performance culture they forgot R&D. It used to be that scientists were passionate about what they did but the only passion now is how can I save my job or how can I get a new one. Sad as both Astra and Zeneca were good companies and the sum could have combined the best of both not the worst.
Of course the Swedes are going. Day in the life of a Swedish researcher:
8am go to work. Have coffee and breakfast.
14.30 start an experiment.
14.37 give up on experiment du to reagent shortage.
14.38 coffee and cake
16.30 go home.
About as productive as a rhododendron and slightly more toxic.
Mölndal is toast. CVGI is toast. R&I will be moved to Alderley, and all the ex-pats will be left in the wilderness.
Sorry, Swedes not Sweds.
I think the Sweds will be wiped from history. Astra R&D has been even worse than Zenecas. Big question is what will the company be called when it does the inevitable mega merger, probably with Abbvie. AbbvieZeneca anyone?
What?! The sacred cow of Alderley Park is vulnerable - I think not.
From what Soriot said today respiratory is one of his main priorities which would mean Molndal is probably not in his sites. Alderley's only research area is now oncology, which wasn't mentioned as one of the five priorities - Alderley looks more vulnerable.
See, like I said.
Next aquire Shire, merge with Abbvie
New CEO doesn't exclude a larger M&A: Looks like you're right. Question is: who will we cut to finance this?
Thus the wheel of fortune spins again:
an A for Alderly Park
a B for Boston
an M for HIGH LIKELIHOOD
God natt Mölndal
Latest comments from new Mr Big to accompany the profit warning say they'll develop strong scientific leadership; so thats more senior managers and less scientists in the lab again.
It will be the same old courageous twaddle as 2010. Good luck, old friends.
Whether tomorrow or beginning of March: this is the third year running (to my count) that AstraZeneca is "restructuring". I have a hard time believing anyone can focus on the core business (developing drugs, for those of you who have forgotten) in such an environment.
No restructuring announcement tomorrow this will be made beginning of March
Any predictions about tomorrow's announcements?
Err - where else?
Head of CVGI in Mölndal?
The restructuring announcement will be beginning March not end January. The head of CVGI left after a major disagreement with our Greek friend. Related to closure of CVGI or large reduction of head count in said department
If it goes to the usual pattern the announcement will be postponed three times before its finally revealed...
See, like I said.
Next aquire Shire, merge with Abbvie
"Hi guys, AstraZeneca hasn't announced a restructuring plan that I can see. Is this just speculation that one might be on the way?"
new CEO, Soriot, has stated that he will be announcing his strategy at the end of January.
Hi guys, AstraZeneca hasn't announced a restructuring plan that I can see. Is this just speculation that one might be on the way?
MM on his way out I reckon.
We would we be without irony!
Maybe he'll announce the need to open new research sites in the East Midlands, Sweden and the US & Canada.
More information about formatting options